| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/09/2011 | CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 02/09/2011 | CN101338459B Method for preparing organic and inorganic nanometer assorted fibre |
| 02/09/2011 | CN101322727B Exterior patch for freeing collateral vessels and dispelling pain and producing method thereof |
| 02/09/2011 | CN101292960B Sustained-release microsphere containing risperidone and preparation method thereof |
| 02/09/2011 | CN101274097B Atomizing grippe vaccine composition and preparation thereof |
| 02/09/2011 | CN101272766B Composition for administration to mammals or humans |
| 02/09/2011 | CN101178961B Water soluble magnetic nanometer crystal with high dissolvability and method of producing the same |
| 02/09/2011 | CN101084880B Biological solid dispersion of vitamin E esters derivatives and preparation method thereof |
| 02/08/2011 | USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884178 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 02/08/2011 | US7884083 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 02/08/2011 | US7884071 Gels containing luteinizing hormone releasing hormone antagonist (ozarelix) in lyophilized form, aqueous solution of sodium chloride; colloids; for treating hormone related disorders, prostate cancer, breat cancer, uterine myomas, endometriosis, puberty disorders, and reproductive disorders |
| 02/08/2011 | US7883722 erodible matrix comprising drugs, coatings comprising cellulose derivatives which is insoluble in aqueous medium and a second cellulose derivative which is water soluble, plasticizers and fillers, for drug delivery into an aqueous medium by erosion at controlled rates; time-release agents |
| 02/08/2011 | US7883720 Charge-dynamic polymers and delivery of anionic compounds |
| 02/08/2011 | US7883719 Pasting agent |
| 02/08/2011 | US7883713 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans |
| 02/08/2011 | US7883709 Stabilised compositions |
| 02/08/2011 | US7883697 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 02/08/2011 | US7883694 Method for preventing the formation of adhesions following surgery or injury |
| 02/08/2011 | US7883692 Polymer comprising water soluble units and LCST units, and aqueous composition comprising same |
| 02/08/2011 | US7883032 Devices and formulations |
| 02/08/2011 | CA2616531C Sterile, drop-forming, multiphase, emulsifier-free ophthalmic preparation |
| 02/08/2011 | CA2540984C A solid dosage form comprising a fibrate |
| 02/08/2011 | CA2456604C Pharmaceutical composition comprising lumiracoxib |
| 02/08/2011 | CA2409854C Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds |
| 02/08/2011 | CA2409660C Novel process |
| 02/08/2011 | CA2403475C Device and method for treating urinary incontinence in females |
| 02/08/2011 | CA2401424C Alprazolam inclusion complexes and pharmaceutical compositions thereof |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/08/2011 | CA2345815C Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2275525C Gel composition and methods |
| 02/08/2011 | CA2258097C Insulin preparations containing nacl |
| 02/08/2011 | CA2220871C Peptide/protein suspending formulations |
| 02/03/2011 | WO2011014588A2 Dermal formulations of dp2 receptor antagonists |
| 02/03/2011 | WO2011013794A1 Water-based composition for eye drop |
| 02/03/2011 | WO2011013791A1 Kidney-targeting drug delivery agent comprising genetically modified gelatin |
| 02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013698A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013639A1 Tablet |
| 02/03/2011 | WO2011013592A1 Coated preparation |
| 02/03/2011 | WO2011013546A1 Water-soluble polymer composition, composition for forming plaster layer of skin patch, and skin patch |
| 02/03/2011 | WO2011013359A1 Medicinal composition for iontophoresis |
| 02/03/2011 | WO2011013130A2 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 02/03/2011 | WO2011013128A2 Vectors for delivery of neurotherapeutics to the central nervous system |
| 02/03/2011 | WO2011012989A1 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | WO2011012866A1 Solutions comprising polyethylene glycol and electrolytes |
| 02/03/2011 | WO2011012850A2 Glycopolysialylation of non-blood coagulation proteins |
| 02/03/2011 | WO2011012816A2 Pharmaceutical formulation |
| 02/03/2011 | WO2011012774A1 Novel form of osteogenic protein administration |
| 02/03/2011 | WO2011012729A1 Use of constrained dipeptide and tripeptide mimic oligomers as vectorization agents |
| 02/03/2011 | WO2011012723A1 Injectable sustained release compositions comprising a pramipexole prodrug |
| 02/03/2011 | WO2011012722A1 Prodrugs containing an aromatic amine connected by an amido bond to a linker |
| 02/03/2011 | WO2011012721A1 Carrier linked pramipexole prodrugs |
| 02/03/2011 | WO2011012719A1 Long acting insulin composition |
| 02/03/2011 | WO2011012718A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | WO2011012715A1 Biodegradable polyethylene glycol based water-insoluble hydrogels |
| 02/03/2011 | WO2011012312A1 Bladder instillation compositions for treating bladder cancer |
| 02/03/2011 | WO2011012162A1 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer |
| 02/03/2011 | WO2011011978A1 Nanosphere or microsphere drug carrier, preparation method, composition and use thereof |
| 02/03/2011 | WO2011011879A1 H. pylori lipopolysaccharide outer core epitope |
| 02/03/2011 | WO2011011873A1 Sticky soft gel for treating poultry |
| 02/03/2011 | WO2010144869A3 Covalent conjugates comprising a protease inhibitor, a water-soluble, non-peptidic oligomer and a lipophilic moiety |
| 02/03/2011 | WO2010111680A3 Dry powder formulations and methods for treating pulmonary diseases |
| 02/03/2011 | WO2010111215A3 Compositions and methods for treatment of hemorrhage |
| 02/03/2011 | WO2010111178A3 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 02/03/2011 | WO2010096320A3 Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| 02/03/2011 | WO2010053597A3 Micelles of hydrophilically shielded membrane-destabilizing copolymers |
| 02/03/2011 | WO2010018003A3 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/03/2011 | WO2009158412A8 Sustained delivery of exenatide and other polypeptides |
| 02/03/2011 | WO2009150284A9 Apo-a conjugates for the administration of biologically active compounds |
| 02/03/2011 | WO2009132050A9 Auris formulations for treating otic diseases and conditions |
| 02/03/2011 | WO2008006204A3 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028570 Self emulsifying granules and process for the preparation of emulsions therefrom |
| 02/03/2011 | US20110028569 Mixtures of hydrolysis resistant organomodified trisiloxane ionic surfactants |
| 02/03/2011 | US20110028568 Preparation for magnesium ammonium phosphate cements |
| 02/03/2011 | US20110028555 Antiinflammatory and Analgesic Preparation for External Use |
| 02/03/2011 | US20110028535 Oligonucleotides-transferring preparations |
| 02/03/2011 | US20110028480 Orodispersable formulations of phosphodiesterase-5 (pde-5) inhibitors |
| 02/03/2011 | US20110028457 Pharmaceutical preparation comprising permethylated cyclodextrin |
| 02/03/2011 | US20110028406 Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110027379 Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
| 02/03/2011 | US20110027369 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 02/03/2011 | US20110027367 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027350 Glycopolysialylation of non-blood coagulation proteins |
| 02/03/2011 | US20110027332 Pliable medical device and method of use |
| 02/03/2011 | US20110027331 An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| 02/03/2011 | US20110027307 Anti-sepsis conjugate vaccine |
| 02/03/2011 | US20110027272 Stabilized liquid anti-rsv antibody formulations |
| 02/03/2011 | US20110027217 Immunomodulatory agent-polymeric compounds |
| 02/03/2011 | US20110027204 title compound is adapalene; acne gel or cream |
| 02/03/2011 | DE102009040624B3 Use of dried water kefir grains as a carrier of oil-like substances in an inexpensive manner |
| 02/03/2011 | DE102009034308A1 Medizinisches Präparat zur Behandlung von entzündlichen Prozessen Medicinal preparation for the treatment of inflammatory processes |
| 02/03/2011 | CA2805511A1 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique |